PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
3.970
+0.030 (0.76%)
At close: Dec 5, 2025, 4:00 PM EST
3.968
-0.002 (-0.04%)
After-hours: Dec 5, 2025, 7:09 PM EST
PolyPid Employees
As of December 31, 2024, PolyPid had 60 total employees, including 57 full-time and 3 part-time employees. The number of employees decreased by 2 or -3.23% compared to the previous year.
Employees
60
Change (1Y)
-2
Growth (1Y)
-3.23%
Revenue / Employee
n/a
Profits / Employee
-$570,267
Market Cap
66.04M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PYPD News
- 3 days ago - PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX₁₀₀ Supporting NDA Submission - GlobeNewsWire
- 11 days ago - PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025 - GlobeNewsWire
- 23 days ago - PolyPid Ltd. (PYPD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 24 days ago - PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 weeks ago - PolyPid's D-PLEX₁₀₀ Wins BioTech Breakthrough Award for "Therapeutics Solution of the Year" - GlobeNewsWire
- 5 weeks ago - PolyPid to Report Third Quarter 2025 Financial Results and Operational Highlights on November 12, 2025 - GlobeNewsWire
- 2 months ago - PolyPid to Present Its Positive Phase 3 SHIELD II Topline Results at the 2025 American College of Surgeons Clinical Congress - GlobeNewsWire
- 2 months ago - PolyPid to Present at Lytham Partners Fall 2025 Investor Conference and Participate in 4th Annual ROTH Healthcare Opportunities Conference - GlobeNewsWire